The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with ...

Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...

KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended the review of its drug for a ...

Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after ...

Police across Europe have dismantled a dark web drug marketplace known as 'Archetyp Market', the pan-European Europol police ...

Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...

The global watchdog of doping in sports says it will urge public authorities to shut down the drug-fueled Enhanced Games ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...

For decades, pharmaceutical companies have shelled out big bucks to broadcasters to place ads between segments. But a pair of policies being considered by Health and Human Services Secretary Robert F.

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...